Search
Precigen Inc
PGENAdd to Watchlist
6.680USD
-0.120-1.76%
Close 09-10 16:00（ET）
2.39BMarket Cap
LossP/E TTM
After-hours (ET)0.000USD0.000
After-hours (ET)Precigen Inc (PGEN) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Precigen Inc in the past month.
Buy
0 Strong Buy
2 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
14.500USD+104.23%
PGEN Analyst Recommendation Trends
In the current month, PGEN has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PGEN average Analyst price target in the last month is 14.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
PGEN Analyst Rating for Peer Comparison
Updated: Sep 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
AbbVie Inc
ABBV
7
19
6
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, PGEN EPS is projected to reach 0.080 in FY2026Q3, following reported EPS of 0.056 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.08
-0.03
-0.01
0.08
0.11
Actual
-0.07
-0.02
0.06
--
--
Surprise
+20.39%
+30.06%
+521.91%
--
--
FAQs
What is Precigen Inc's expected revenue for the next quarter?
Precigen Inc's expected revenue is 69.21M.
What is Precigen Inc's price target?
Analysts forecast that Precigen Inc's price target is USD 8.50, with the highest forecast at USD 9.00 and the lowest forecast at USD 8.00.
How have Precigen IncPGEN's recent earnings per share performed?
The market expectation was USD 0.06, while Precigen IncPGEN's earnings per share (EPS) for the previous quarter was USD -0.02. EPS for the next quarter is expected at USD 0.08.
What is the analyst rating for Precigen Inc?
Based on the ratings of Precigen Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.